Form 4: Cigna Executive Noelle K. Eder Reports Stock Transactions
SEC Form 4
Noelle K. Eder, EVP and Global Chief Information Officer of Cigna Group, reports the acquisition and disposal of company stock and stock options under a pre-arranged trading plan and 401(k) participation.
Summary
- Noelle K. Eder, an executive at Cigna Group, filed a Form 4 detailing changes in beneficial ownership of the company's stock.
- On May 14, 2024, Eder acquired 5,533 shares of common stock at $171.385 per share through the exercise of employee stock options and disposed of 10,700 shares at $348.47 per share.
- On May 15, 2024, Eder acquired an additional 875 shares at $171.385 per share through option exercise.
- Eder also reported acquiring shares through participation in The Cigna Group's 401(k) Plan.
- These transactions were executed under a Rule 10b5-1 trading plan adopted on February 9, 2024.
- Following these transactions, Eder directly owns 16,699 shares and indirectly owns 176.0434 shares through a 401(k).
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing simply reports transactions executed under a pre-existing plan. There's no indication of positive or negative sentiment towards the company's prospects.
Positives
- The executive's transactions are part of a pre-planned trading strategy, suggesting a structured approach to managing their holdings.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.
Comparison to Industry Standards
- Executive compensation packages often include stock options to align management's interests with those of shareholders.
- Rule 10b5-1 trading plans are a common mechanism for executives to manage their stock holdings while avoiding accusations of insider trading.
- Comparing Eder's transactions to those of executives at peer companies like UnitedHealth Group or Anthem (now Elevance Health) could provide a broader context.
Stakeholder Impact
- The transactions may have a minor impact on shareholders by slightly increasing the number of shares available in the market.
- The use of a 10b5-1 plan ensures transparency and reduces concerns about insider trading, which benefits all stakeholders.
Key Dates
| Date | Description |
|---|---|
| 09/14/2020 | Date employee stock option was granted. |
| 09/14/2021 | First vesting date of the employee stock option. |
| 02/09/2024 | Date the Rule 10b5-1 trading plan was adopted. |
| 05/14/2024 | Date of stock acquisition and disposal. |
| 05/15/2024 | Date of stock acquisition. |
| 05/16/2024 | Date of Form 4 filing. |
| 09/14/2030 | Expiration date of the employee stock option. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.